Hanall Biopharma (009420) — Tangible Net Worth Ratio
Hanall Biopharma (009420) has a Tangible Net Worth Ratio of 61.0% as of September 2025. This metric is calculated by deducting intangible assets (₩61.54 Billion) from net assets (₩157.65 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 009420 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hanall Biopharma Tangible Net Worth Ratio (2011–2024)
This chart shows how Hanall Biopharma's Tangible Net Worth Ratio has changed across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 61.0%, reflecting net assets of ₩157.65 Billion with intangible assets of ₩61.54 Billion KRW. See Hanall Biopharma (009420) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Hanall Biopharma (2011–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Hanall Biopharma from 2011 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 009420 market cap overview.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 69.2% | ₩168.35 Billion | ₩51.81 Billion | ₩212.88 Billion | ▼ -13.3 pp |
| 2023 | 82.5% | ₩186.22 Billion | ₩32.61 Billion | ₩239.75 Billion | ▼ -3.3 pp |
| 2022 | 85.8% | ₩168.26 Billion | ₩23.84 Billion | ₩213.45 Billion | ▼ -2.5 pp |
| 2021 | 88.3% | ₩163.49 Billion | ₩19.10 Billion | ₩198.48 Billion | ▼ -3.4 pp |
| 2020 | 91.7% | ₩181.27 Billion | ₩15.08 Billion | ₩220.13 Billion | ▼ -0.7 pp |
| 2019 | 92.4% | ₩140.42 Billion | ₩10.72 Billion | ₩191.38 Billion | ▼ -2.9 pp |
| 2018 | 95.3% | ₩116.92 Billion | ₩5.52 Billion | ₩162.30 Billion | ▲ +4.4 pp |
| 2017 | 90.9% | ₩111.20 Billion | ₩10.16 Billion | ₩168.70 Billion | ▲ +2.0 pp |
| 2016 | 88.8% | ₩104.36 Billion | ₩11.65 Billion | ₩124.73 Billion | ▼ -8.3 pp |
| 2015 | 97.2% | ₩95.22 Billion | ₩2.71 Billion | ₩117.13 Billion | ▲ +4.5 pp |
| 2014 | 92.6% | ₩45.81 Billion | ₩3.39 Billion | ₩87.17 Billion | ▼ -1.1 pp |
| 2013 | 93.7% | ₩59.63 Billion | ₩3.74 Billion | ₩97.85 Billion | ▼ -2.9 pp |
| 2012 | 96.6% | ₩78.67 Billion | ₩2.69 Billion | ₩124.27 Billion | ▲ +1.4 pp |
| 2011 | 95.2% | ₩50.70 Billion | ₩2.46 Billion | ₩105.46 Billion | — |